128 related articles for article (PubMed ID: 28566093)
1. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
[TBL] [Abstract][Full Text] [Related]
2. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
Yu YL; Tseng WK; Liao CK; Yeh CY; Chen HH; Liu YH; Liaw YW; Fan CW
BMC Cancer; 2023 Sep; 23(1):900. PubMed ID: 37749535
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer.
Imano N; Murakami Y; Kubo K; Kawahara D; Takeuchi Y; Nishibuchi I; Kimura T; Kochi M; Takakura Y; Shimizu W; Egi H; Uegami S; Ohge H; Takahashi S; Ohdan H; Nagata Y
J Radiat Res; 2021 Mar; 62(2):300-308. PubMed ID: 33341902
[TBL] [Abstract][Full Text] [Related]
4. N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
Miyashita S; Shimizu T; Ishizuka M; Niki M; Nishi Y; Shibuya N; Hachiya H; Matsumoto T; Sakuraoka Y; Shiraki T; Mori S; Iso Y; Irisawa A; Aoki T
Anticancer Res; 2023 May; 43(5):2219-2225. PubMed ID: 37097679
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.
Yasui M; Ikeda M; Sekimoto M; Yamamoto H; Takemasa I; Ueda T; Shimizu J; Fukunaga M; Suzuki O; Inoue T; Monden M
World J Surg Oncol; 2006 Nov; 4():83. PubMed ID: 17118210
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival results of surgery alone versus surgery plus UFT (Uracil and Tegafur)-based adjuvant therapy in patients with stage II colon cancer.
Lin BR; Lai HS; Chang TC; Lee PH; Chang KJ; Liang JT
J Gastrointest Surg; 2011 Dec; 15(12):2239-45. PubMed ID: 21993974
[TBL] [Abstract][Full Text] [Related]
7. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
Cassidy RJ; Switchenko JM; Cheng E; Jiang R; Jhaveri J; Patel KR; Tanenbaum DG; Russell MC; Steuer CE; Gillespie TW; McDonald MW; Landry JC
Cancer; 2017 Nov; 123(22):4325-4336. PubMed ID: 28759121
[TBL] [Abstract][Full Text] [Related]
8. Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial.
Marti FEM; Jayson GC; Manoharan P; O'Connor J; Renehan AG; Backen AC; Mistry H; Ortega F; Li K; Simpson KL; Allen J; Connell J; Underhill S; Misra V; Williams KJ; Stratford I; Jackson A; Dive C; Saunders MP
Eur J Cancer; 2019 Aug; 117():48-59. PubMed ID: 31229949
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications.
Wang Y; Wang X; Chen J; Huang S; Huang Y
Updates Surg; 2024 Jan; ():. PubMed ID: 38240957
[TBL] [Abstract][Full Text] [Related]
10. Role of Radical Surgery Following Preoperative Chemoradiotherapy in Octogenarians With Rectal Cancer: A SEER Analysis.
Lim YJ; Kong M
Anticancer Res; 2024 Jan; 44(1):417-425. PubMed ID: 38159981
[TBL] [Abstract][Full Text] [Related]
11. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.
Glimelius B
Ups J Med Sci; 2017 Mar; 122(1):1-10. PubMed ID: 28256956
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neoadjuvant oral chemotherapy with UFT plus Folinic acid or Capecitabine concomitant with radiotherapy on locally advanced rectal cancer.
Conde S; Borrego M; Teixeira T; Teixeira R; Sá A; Soares P
Rep Pract Oncol Radiother; 2012; 17(6):376-83. PubMed ID: 24377041
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
Charlton ME; Lin C; Jiang D; Stitzenberg KB; Halfdanarson TR; Pendergast JF; Chrischilles EA; Wallace RB
Am J Clin Oncol; 2013 Dec; 36(6):572-9. PubMed ID: 22992624
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pathological response of standard chemoradiotherapy versus short course radiotherapy in rectal carcinoma: A pilot study.
Nagarjun BR; Shah A; Gami A; Gandhi J; Parikh A; Modi V
Indian J Pathol Microbiol; 2023; 66(4):708-713. PubMed ID: 38084520
[TBL] [Abstract][Full Text] [Related]
15. Number of Healthy Teeth Can Predict the Response of Rectal Cancer to Chemoradiotherapy: A Retrospective Study.
Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T
Am Surg; 2024 Apr; ():31348241244628. PubMed ID: 38636083
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer.
De Felice F; Musio D; Izzo L; Pugliese F; Izzo P; Bolognese A; Tombolini V
Biomed Res Int; 2013; 2013():610786. PubMed ID: 24392453
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
Peng J; Ma W; Zhou Z; Gu Y; Lu Z; Zhang R; Pan Z
J Cancer; 2018; 9(6):1067-1077. PubMed ID: 29581786
[No Abstract] [Full Text] [Related]
18. Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA; Hsieh MC
Am J Cancer Res; 2023; 13(11):5504-5512. PubMed ID: 38058839
[TBL] [Abstract][Full Text] [Related]
19. Generalizability of Randomized Controlled Trials in Rectal Cancer.
Hsu S; Rosen KJ; Cupertino A; Temple L; Fleming F
J Gastrointest Surg; 2022 Feb; 26(2):453-465. PubMed ID: 34755313
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Complete Onychomadesis after Oral UFT/LV Therapy with Long-Term Follow-Up].
Kojima K; Habiro T; Waraya M; Hayashi K; Naitoh T; Ishii K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1351-1353. PubMed ID: 38247080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
